3 completed, 1 unknown, 1 withdrawn. 5 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 3, Unknown 1, Withdrawn 1 |
| Phase 2 | 2 | Unknown 1, Withdrawn 1 |
Follow Histamine: new trials by email Literature Review of Histamine trials Research Report on Histamine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of HDC/IL-2 Treatment in Chronic Myelomonocytic Leukemia (CMML) Cohort 1, Ceplene® and Proleukin®, Cohort 2, Ceplene® and Proleukin®, Cohort 3, Ceplene® and Proleukin® - Leukemia, Myelomonocytic, Chronic | Phase 1 / Phase 2 | Unknown | Vastra Gotaland Region | 15 | 2017-02-15 | 2017-12-19 |
| Immunologic Profile of Chronically Photodamaged Skin Candida albicans antigen, histamine phosphate, imiquimod 5% cream - Photoaged Skin, Normal Skin | Phase 1 | Completed | University of Michigan | 40 | 2016-06-06 | 2025-02-13 |
| TransMEM Gas Exchange -- Project 1, Aim 2 ragweed, histamine, pseudoephedrine - Middle Ear Disease, Nasal Allergy | Phase 1 | Completed | Cuneyt M. Alper | 84 | 2013-10-01 | 2020-02-07 |
| Azacitidine With or Without Ceplene/Interleukin-2 in Patients With Higher Risk Myelodysplastic Syndromes Ceplene®, IL-2, Azacitidine, Azacitidine - Myelodysplastic Syndromes | Phase 1 / Phase 2 | Withdrawn | Groupe Francophone des Myelodysplasies | 2011-03-01 | 2014-03-20 | |
| Skin Prick Tests With AllerT in Subjects Allergic to Birch Pollen placebo, Histamine, AllerT1 - Allergic Rhinitis | Phase 1 | Completed | Anergis | 20 | 2008-02-01 | 2012-11-01 |
Hypersensitivity (2) · Leukemia, Myelomonocytic, Chronic (1) · Myelodysplastic Syndromes (1) · Rhinitis, Allergic (1)
Anergis (1) · Cuneyt M. Alper (1) · Groupe Francophone des Myelodysplasies (1) · University of Michigan (1) · Vastra Gotaland Region (1)
United States (2) · France (1) · Sweden (1) · Switzerland (1)
Cuneyt M Alper, MD (1) · Francois Spertini, MD (1) · Pierre Fenaux, MD (1) · Yolanda Helfrich, MD (1)
P50DC007667 (1)